Genzyme and Isis announce FDA approval of KYNAMRO™ injection for the treatment of HoFH
29 January 2013 | By Sanofi
“Today’s FDA approval of KYNAMRO is great news..."
List view / Grid view
29 January 2013 | By Sanofi
“Today’s FDA approval of KYNAMRO is great news..."
28 January 2013 | By Sanofi
Genzyme also reports very encouraging early launch indicators for AUBAGIO® (teriflunomide) in U.S.
28 January 2013 | By Sanofi
Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions...
8 January 2013 | By Sanofi
Sanofi will provide an update on its Research & Development (R&D) pipeline...
7 January 2013 | By Sanofi
“I am delighted that Dr. Gary Nabel will continue to make this Council a vital part of our efforts..."
18 December 2012 | By Sanofi
Sanofi announced that Hanspeter Spek, President, Global Operations, will retire from his current role in mid-2013...
14 December 2012 | By Sanofi
"We are disappointed by the Committee's recommendation..."
9 December 2012 | By Sanofi
New data presented at American Society of Hematology Annual Meeting show activity against disease and symptom alleviation...
3 December 2012 | By Sanofi
American Society of Hematology, Atlanta, GA., 8-11 December, 2012...
28 November 2012 | By Sanofi
Sanofi ranked third among twenty pharmaceutical companies on the 2012 Access to Medicine Index (ATM Index)...
16 November 2012 | By Sanofi
“We are pleased that CHMP has supported our ZALTRAP application..."
16 November 2012 | By Sanofi
“The CHMP positive opinion for Lyxumia marks an important milestone..."
14 November 2012 | By Sanofi
Sanofi is pleased to announce the appointment of Dr. Gary J. Nabel...
14 November 2012 | By
Collaboratation on the TEENs registry study...
31 October 2012 | By
Significant effects of LEMTRADA™ vs. Rebif ® described in CARE-MS I and CARE-MS II publications...